Verve Therapeutics Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Mar '25 Mar 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Cash & Equivalents	77,366	54,003	41,317	19,701
Cash & Short-Term Investments	84,347	54,003	41,317	19,701
Cash Growth	328.13%	30.70%	109.72%	-
Accounts Receivable	23,535	20,123	13,724	8,613
Other Receivables	1,046	1,180	496.48	355.22
Receivables	24,581	21,303	14,220	8,968
Inventory	46,093	47,900	16,966	7,162
Prepaid Expenses	3,396	3,619	529.7	123.97
Other Current Assets	2,510	1,484	501.95	412.16
Total Current Assets	160,926	128,309	73,535	36,368
Property, Plant & Equipment	3,893	4,187	1,979	1,892
Long-Term Investments	99.48	99.48	-	-
Other Intangible Assets	346.66	361.97	80.8	81.48
Long-Term Accounts Receivable	0	0	0	0
Long-Term Deferred Tax Assets	2,196	2,252	2,028	772.1
Other Long-Term Assets	908.63	898.69	380.84	242.48
Total Assets	168,370	136,108	78,004	39,356
Accounts Payable	9,169	7,969	6,493	4,240
Accrued Expenses	2,671	2,330	2,724	171.28
Current Portion of Leases	850.93	831.18	333.06	231
Current Income Taxes Payable	13,205	11,155	2,859	2,877
Other Current Liabilities	14,563	9,036	38,683	22,344
Total Current Liabilities	40,459	31,320	51,092	29,863
Long-Term Leases	1,767	1,988	1,100	1,050
Long-Term Deferred Tax Liabilities	291.14	-	16.25	-
Other Long-Term Liabilities	755.6	718.44	140.8	134.98
Total Liabilities	43,713	34,039	57,544	33,245
Common Stock	1,147	1,147	889.58	865.65
Additional Paid-In Capital	73,879	73,806	99.03	3,419
Retained Earnings	46,964	25,802	13,057	-3,765
Comprehensive Income & Other	2,669	1,314	1,469	1,172
Total Common Equity	124,657	102,069	15,514	1,692
Shareholders' Equity	124,657	102,069	20,460	6,110
Total Liabilities & Equity	168,370	136,108	78,004	39,356
Total Debt	2,617	2,819	1,433	1,281
Net Cash (Debt)	81,729	51,184	39,884	18,420
Net Cash Growth	343.69%	28.33%	116.52%	-
Net Cash Per Share	7189.04	4801.20	4277.66	2132.68
Filing Date Shares Outstanding	11.47	11.47	8.9	8.64
Total Common Shares Outstanding	11.47	11.47	8.9	8.64
Working Capital	120,467	96,988	22,443	6,505
Book Value Per Share	10872.22	8902.15	1743.94	195.91
Tangible Book Value	124,311	101,707	15,433	1,611
Tangible Book Value Per Share	10841.99	8870.58	1734.86	186.47
Machinery	521.88	494.65	104.97	87.04
Construction In Progress	-	-	32.5	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.